Kuros Biosciences’ bone graft approved for spine use

Kuros Biosciences’ MagenetOs Flex Matrix was cleared by the FDA for use as a bone void filler in the posterolateral spine.

Advertisement

MagnetOs Flex is an open matrix bone graft designed for more predictable spinal fusions, according to an April 21 news release. It has a fibrillar and flexible structure that optimizes the company’s pro-healing NeedleGrip surface technology.

This is the third FDA clearance for Kuros’ MagnetOs product family in the last seven months.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.